Similar Items: Metalloproteinases and their inhibitors as therapeutic targets for multiple sclerosis: current evidence and future perspectives
- Are matrix metalloproteinases and their inhibitors reliable diagnosis biomarkers and attractive therapeutic targets in endometriosis?
- Metalloproteinases and their inhibitors in the pathophysiology of heritable connective tissue disorders: current evidence
- Metalloproteinases and neurodegenerative diseases: pathophysiological and therapeutic perspectives
- Metalloproteinases as modulators of allergic asthma: therapeutic perspectives
- Nonproteolytic functions of matrix metalloproteinases in pathology and insights for the development of novel therapeutic inhibitors
- Matrix metalloproteinases in cystic fibrosis: pathophysiologic and therapeutic perspectives